The hypomethylation of ADAM17 in PAAD tumor tissues appeared to be positively correlated with the higher expression shown in our previous report, implying that hypomethylation of the ADAM17 promotor may be responsible for its increased expression in PAAD tissues. The gene discussed is ADAM17; the disease is pancreatic adenocarcinoma.